R. Spangenberg

发表

Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.

W. Parmley, E. Botvinick, P. Lanzer, 1984, American heart journal.

Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.

W. Parmley, D. Kereiakes, K. Chatterjee, 1984, Journal of the American College of Cardiology.

Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.

J. F. Lang, P. Reddy, B. Uretsky, 1984, The American journal of cardiology.

Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.

R. Kehoe, T. Zheutlin, C. Dunnington, 1993, The American journal of cardiology.

Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias.

R. Kehoe, T. Zheutlin, T. Mattioni, 1990, The American journal of cardiology.

The Acute Hemodynamic Effects of a New Agent, MDL 17,043, in the Treatment of Congestive Heart Failure

P. Reddy, B. Uretsky, W. Follansbee, 1983, Circulation.

A gill disease in the eel, caused by Dermocystidium anguillae n.sp.

R. Spangenberg, 1975 .

Biochemical adaptation of juvenile carp (Cyprinus carpio L.) to food deprivation

R. Bastrop, K. Jürss, R. Spangenberg, 1991 .

Effect of glucagon in hemorrhagic shock

J. Hook, R. Spangenberg, D. A. Vanderwall, 1970, Journal of surgical oncology.

Clinical safety profile of sotalol in patients with arrhythmias.

L. Soyka, C. Wirtz, R. Spangenberg, 1990, The American journal of cardiology.

Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.

F. Shellock, H. Swan, D. Amin, 1985, American heart journal.